跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DBL POTASSIUM ACETATE CONCENTRATED INJECTION 2.45 G/5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
DBL POTASSIUM ACETATE CONCENTRATED INJECTION 2.45 G/5 ML
Approved
THERAPEUTIC
DBL POTASSIUM ACETATE CONCENTRATED INJECTION 2.45 G/5 ML
SIEGFRIED HAMELN GMBH (GERMANY)
🇸🇬 Health Sciences Authority
Approval Date
May 21, 1991
Approval ID
d323be9abb81bb2a
Company
SIEGFRIED HAMELN GMBH (GERMANY)
Type
Therapeutic
Approval Details
Approval Id
d323be9abb81bb2a
Drug Name
DBL POTASSIUM ACETATE CONCENTRATED INJECTION 2.45 G/5 ML
Product Name
DBL POTASSIUM ACETATE CONCENTRATED INJECTION 2.45 G/5 ML
Approval Number
SIN05868P
Approval Date
1991-05-21
Registrant
PFIZER PRIVATE LIMITED
Licence Holder
PFIZER PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS
Atc Code
B05XA17
Atc Item Name
potassium acetate
Pharma Manufacturer Name
PFIZER PRIVATE LIMITED
Active Ingredients
POTASSIUM ACETATE (ANHYDROUS)
2.45 g/5 ml
POTASSIUM ACETATE (ANHYDROUS)
2.45 G/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 21, 1991
Approval ID
d323be9abb81bb2a
Type
Therapeutic
Back to HSA Approvals
